✦ LIBER ✦

White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy

✍ Scribed by Weber, J.; Atkins, M.; Hwu, P.; Radvanyi, L.; Sznol, M.; Yee, C.

Book ID: 121864556
Publisher: American Association for Cancer Research
Year: 2011
Tongue: English
Weight: 234 KB
Volume: 17
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-10-2272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Minimally invasive liver resection to ob

Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma

✍ Melissa M Alvarez-Downing, Suzanne M Inchauste, Mark E Dudley, Donald E White, J 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 263 KB

Randomized Selection Design Trial Evalua

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

✍ Dudley, M. E.; Gross, C. A.; Somerville, R. P. T.; Hong, Y.; Schaub, N. P.; Rosa 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 186 KB

A randomized trial of adoptive immunothe

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer

✍ Giovanni B. Ratto; Paolo Zino; Sandro Mirabelli; Paolo Minuti; Riccardo Aquilina 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

A previous pilot study from our group suggested that: (1) adoptive immunotherapy (AI) with tumor-infiltrating lymphocytes (TIL) and recombinant interleukin-2 (rIL-2) may be applied with safety to more than 80% of the patients who had surgery for Stage 111 nonsmall cell lung carcinoma (NSCLC); and (2